AUPH Q3 2020 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000-87.4% YoY

Gross Profit

$29,000100.0% margin

Operating Income

-$42M-145913.8% margin

Net Income

-$42M-145275.9% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$33M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$462M

Total Liabilities

$63M

Stockholders' Equity

$399M

Cash & Equivalents

$249M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$230,000	-87.4%
Gross Profit	$29,000	-$18M	+100.2%
Operating Income	-$42M	-$24M	-76.2%
Net Income	-$42M	-$19M	-121.3%